FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$25.98 B | $26.32 B | $28.19 B | $33.42 B | $36.75 B | $37.24 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$6.45 B | $6.41 B | $8.42 B | $12.86 B | $6.42 B | $10.63 B |
Gross Profit Revenue minus cost of revenue. |
|
$19.53 B | $19.92 B | $19.78 B | $20.57 B | $30.33 B | $26.61 B |
|
Operating Expense
Costs to run business. 
|
|
$11.89 B | $10.35 B | $11.84 B | $13.31 B | $15.44 B | $14.83 B |
Operating Income Profit from operations. |
|
$7.64 B | $9.57 B | $7.90 B | $7.26 B | $14.89 B | $11.78 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$1.20 B | -$1.41 B | -$2.88 B | -$3.16 B | -$2.76 B | -$2.70 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$259.00 M | $814.00 M | -$2.83 B | -$506.00 M | $3.14 B | -$1.79 B |
Total Other Income (Net) Net non-operating items. |
|
-$938.00 M | -$2.22 B | -$42.00 M | -$2.65 B | -$5.92 B | -$2.69 B |
Income Before Tax Profit before taxes. |
|
$6.70 B | $7.35 B | $7.86 B | $4.61 B | $8.98 B | $9.09 B |
Income Tax Expense Taxes on income. |
|
$808.00 M | $794.00 M | $1.14 B | $519.00 M | $1.27 B | $1.29 B |
|
Net Income
Final profit.
|
|
$5.89 B | $6.55 B | $6.72 B | $4.09 B | $7.71 B | $7.80 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$10.34 | $12.18 | $12.56 | $7.56 | $14.33 | $14.48 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$10.28 | $12.11 | $12.49 | $7.56 | $14.23 | $14.37 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
570.00 M | 538.00 M | 535.00 M | 541.00 M | 538.00 M | 540.00 M |
Diluted Average Shares Outst. Shares including dilution. |
|
573.00 M | 541.00 M | 538.00 M | 541.00 M | 542.00 M | 544.00 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$7.90 B | $8.75 B | $10.73 B | $7.76 B | $11.75 B | $13.57 B |
EBITDA Earnings before interest, tax, D&A. |
|
$11.30 B | $12.17 B | $14.80 B | $13.36 B | $17.13 B | $17.35 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$3.40 B | $3.42 B | $4.07 B | $5.59 B | $5.38 B | $3.78 B |
| Company Report |
FY 2025
Amgen's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Amgen's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Amgen's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Amgen's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
